NCT02071381View on ClinicalTrials.gov

Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

DW330SR 45mg

DRUG

DW1030 75mg

Trial Locations (1)

Unknown

Asan Medical Center IRB, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY